Lithium Orotate Natural Lemon Lime Flavor

Lithium Orotate Natural Lemon Lime Flavor

KAL4.7 (2,051 ratings)
Format:Liquid Quantity: 2 Fluid Ounce(s) · 60 servings
Goals
$8.49 $0.14 per serving

Product analysis

91 out of 100

Lithium Orotate Natural Lemon Lime Flavor offers a simple lithium supplement with clear amount and form disclosure and favorable value.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality100

Lithium orotate is a favorable choice of lithium form. Its clear identification makes comparisons between lithium preparations easier.

Ingredient Transparency100

The lithium amount and form are clearly identified. That gives a straightforward basis for comparing servings.

Value For Money80

The serving cost offers favorable value. The single-ingredient approach makes that cost easy to interpret.

Customer Satisfaction85

Customer ratings are strongly positive across a large review pool. They indicate satisfaction without establishing effectiveness or safety.

Product Focus82

The single-ingredient approach appears well aligned with its intended goal. Its narrow scope keeps the combination simple.

Format
Liquid
Container
2 Fluid Ounce(s)
Per serving
$0.14
Customer rating
4.7 · 2,051 ratings
Report analysis

Goals

Mood Support
Impact
Highest effect
A+ Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic

Lithium orotate supplies a low supplemental lithium amount, but a mood benefit at this exposure is not established by the supplied information. Monitored prescription lithium findings do not transfer to this supplement. The declared amount therefore does not establish a demonstrated emotional benefit for generally healthy adults.

How this product is rated for Mood Support

Ingredient fit95

The ingredient selection and known amounts determine how closely this formula relates to mood. Its relevant roles remain subject to the specific nutritional or preparation limits described above.
Goal fit
The declared active ingredient is focused on the named mood goal.
Dose adequacy
The relevant amounts provide a partial match to the saved reference ranges; these ranges do not establish proven effective exposures.

Pathways51

The represented biological areas describe the ingredients' connection to mood; their coverage does not establish a measured improvement in emotional well-being.
Depth
Neuroinflammation and neuroplasticity is the strongest represented area, without establishing a measured mood improvement.
Breadth
One biological areas meet the saved comparison's coverage level; this does not demonstrate multiple independent mood benefits.

Evidence82

The saved ingredient comparison and preparation findings must be read alongside the supplied limits on populations and direct mood outcomes.
Evidence strength
Lithium leads the saved evidence comparison, but the supplied population and outcome limits still govern expected mood benefits.
Studied preparation
The saved comparison accepts the forms with known qualifying amounts; this does not establish routine mood benefit for every ingredient.

Formulation logic100

No specified conflict or missing required partner was identified. The individual amount findings determine which ingredients can be meaningfully compared.
Partner coverage
No required ingredient partner is missing among the ingredients considered; this does not establish added benefit from combining them.
Conflicts
None of the specified ingredient conflicts was identified in the supplied facts.
Effective doses
All ingredients counted here meet the saved minimum amount criterion; that criterion is not proof of an effective mood dose.
Study evidence
Lithium Supportive 197 studies

Ingredients

IngredientAmount per servingScore
Lithium (Lithium Orotate)
4 mg 96
Adults 18–50
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value
A serving provides 4 mg of lithium from lithium orotate. The whole-product serving costs about $0.14.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

Lithium Orotate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.
Lithium Compound Optimization
Lithium Orotate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.

Dose, Safety & Label Transparency100

The stated 4 mg per serving is the amount of lithium itself, making it possible to compare with other amounts given on the same basis.
Elemental Disclosure Precision
The amount of lithium itself is stated as 4 mg per serving, rather than only the weight of its source compound.
Dosage Appropriateness
A serving contains 4 mg of lithium.

Value80

The whole-product serving costs about $0.14 and supplies 4 mg of lithium.
Cost Per Serving Efficiency
The whole-product serving costs about $0.14 and supplies 4 mg of lithium.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M · Bipolar disorders · 2019
    Guideline / consensusMood Support forLithium
  2. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS; GERI-BD Study Group · The American journal of psychiatry · 2017
    Randomized trial224 participantsMood Support forLithium
  3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Lamictal 606 Study Group · Archives of general psychiatry · 2003
    Randomized trial175 participantsMood Support forLithium
  4. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N · Molecular psychiatry · 2022
    Meta-analysis9,821 participants41 studies pooledMood Support forLithium
  5. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R · The Journal of clinical psychiatry · 2004
    Meta-analysis638 participants2 studies pooledMood Support forLithium